Background: Anterior lumbar interbody fusion (ALIF) is an increasingly common surgical procedure for a variety of spinal pathologies. As both opioid use and healthcare costs remain major national healthcare crises, it is crucial to understand methods of effective pain management in spine surgery, including regional anesthesia. While transversus abdominis plane (TAP) blocks are also commonly performed for anterior spinal surgery, literature evaluating outcomes after TAP blocks for ALIF patients is sparse. This retrospective cohort study aims to determine the effect of TAP blocks on perioperative opioid use and hospital length of stay.
Methods: Retrospective chart review was performed for patients 18 years or older undergoing 1- or 2-level ALIF with or without posterior percutaneous instrumented fusion. Baseline demographics, surgical details, length of stay (LOS), and data on inpatient opioid use (converted to morphine milliequivalents, MME) was collected. Total MME and MME stratified by postoperative day (POD) was collected. Bivariable and multivariable regression models were used to analyze the relationship of TAP blocks with LOS and narcotic use postoperatively.
Results: About 295 patients were included, with 102 (34.6%) undergoing TAP block and 193 (65.4%) patients without TAP block. There were no significant differences in baseline patient characteristics. Use of a TAP block had no statistically significant effect on LOS, and bivariable analysis revealed no effect when groups were analyzed by sex, age, BMI, preoperative opioid use, or number of levels fused. TAP block patients received significantly more MME on POD 0 and on combined POD 1 and 2 than those without a TAP block. Bivariable analysis did not reveal any subgroup who benefitted from a TAP block.
Conclusions: With the largest patient cohort reported to date, we found no statistically significant improvements in length of stay or short-term postoperative opioid usage when patients received TAP blocks for anterior lumbar interbody fusion.
Background: Cannabis use in the United States has become increasingly prevalent due to the legislation leading to decriminalization in several states; with increased social acceptance, patients are more willing to disclose cannabis use. Few studies have explored how cannabis may influence a patient's recovery following elective lumbar fusion. Therefore, the purpose of this study was to investigate how cannabis use was associated with patient recovery following elective lumbar fusions.
Methods: This retrospective single institution study included patients ages 35 through 80 years old who had undergone an elective single- or 2-level lumbar fusion between January 2021 and June 2024. Patients were placed into 1 of 3 study groups based on cannabis use, medical cannabis (MC), recreational cannabis (RC), and nonusers (NU). Differences in patient outcomes were assessed through univariate comparison and multivariate regression analyses.
Results: 627 patients were included, 129 (20.3%) admitted to cannabis use, 42 (32.5%) used medical cannabis and 87 (67.5%) used recreationally. Cannabis users were younger than NU (p<0.001) but reported increased pain (p=0.026) and required more opioids (p=0.017). Surgical site infections at 90 days (SSIs) were significantly greater in the MC group (p<0.001).
Conclusions: Cannabis use and type of usage had an impact on patient-reported outcomes, pain level, and measures of surgical success. The MC group had significantly higher opioid consumption and SSI rates at 90 days compared to nonusers and recreational groups. Therefore, this study suggests cannabis use may influence postoperative recovery following elective spine fusion. Additionally, medical cannabis users may be a high-risk group not previously identified in the literature.
Level of evidence: III.

